Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
James D. Berry, Marie Blanchard, Kerina Bonar, Emma Drane, Molly Murton, Uffe Ploug, Kristen Ricchetti-Masterson, Natasa Savic, Emma Worthington & Terry Heiman-Patterson. (2023) Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 436-448.
Read now
Read now
Lisa Meng, Amy Bian, Scott Jordan, Andrew Wolff, Jeremy M. Shefner & Jinsy Andrews. (2018) Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 134-142.
Read now
Read now
Anne Hogden, Geraldine Foley, Robert D Henderson, Natalie James & Samar M Aoun. (2017) Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. Journal of Multidisciplinary Healthcare 10, pages 205-215.
Read now
Read now
Kevin Boylan, Todd Levine, Catherine Lomen-Hoerth, Mary Lyon, Kimberly Maginnis, Peter Callas, Celeste Gaspari & Rup Tandan. (2016) Prospective study of cost of care at multidisciplinary ALS centers adhering to American Academy of Neurology (AAN) ALS practice parameters. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 119-127.
Read now
Read now
Matthew Gladman & Lorne Zinman. (2015) The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 15:3, pages 439-450.
Read now
Read now
Articles from other publishers (30)
Ramya Walsan, Rebecca J. Mitchell, Jeffrey Braithwaite, Johanna Westbrook, Peter Hibbert, Virginia Mumford & Reema Harrison. (2023) Is there an association between out-of-pocket hospital costs, quality and care outcomes? A systematic review of contemporary evidence. BMC Health Services Research 23:1.
Crossref
Crossref
Katie Stenson, Lasair O'Callaghan, Jennifer Mellor, Jack Wright, Gregor Gibson, Lucy Earl, Sophie Barlow & Christina Nicole Fournier. (2023) Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey. Journal of the Neurological Sciences 452, pages 120764.
Crossref
Crossref
Peijia Zhang, Lianke Wang, Qianyu Zhou, Xiaofang Dong, Yuanli Guo, Panpan Wang, Wenqian He, Rongrong Wang, Tiantian Wu, Zihui Yao, Bo Hu, Yu Wang, Qiang Zhang & Changqing Sun. (2023) A network analysis of anxiety and depression symptoms in Chinese disabled elderly. Journal of Affective Disorders 333, pages 535-542.
Crossref
Crossref
Mario B. PradoJrJr, Geohanna Hamoy-Jimenez & Karen Joy Adiao. (2023) Characteristic and management motor neuron disease in the largest tertiary hospital in the Philippines: A one-year period cross sectional analytic study. Journal of Clinical Neuroscience 112, pages 68-72.
Crossref
Crossref
Gabriel Rodrigues Coutinho Pereira, Bárbara de Azevedo Abrahim-Vieira & Joelma Freire de Mesquita. (2023) In Silico Analyses of a Promising Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis Targeting Superoxide Dismutase I Protein. Pharmaceutics 15:4, pages 1095.
Crossref
Crossref
Christen Shoesmith. 2023. Neuropalliative Care, Part II. Neuropalliative Care, Part II
139
155
.
Lidia García-Pérez, Renata Linertová, Cristina Valcárcel-Nazco, Manuel Posada, Inigo Gorostiza & Pedro Serrano-Aguilar. (2021) Cost-of-illness studies in rare diseases: a scoping review. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
K. Achtert & L. Kerkemeyer. (2021) The economic burden of amyotrophic lateral sclerosis: a systematic review. The European Journal of Health Economics 22:8, pages 1151-1166.
Crossref
Crossref
Kevin Morris, Mohammad Nami, Joe F. Bolanos, Maria A. Lobo, Melody Sadri-Naini, John Fiallos, Gilberto E. Sanchez, Teshia Bustos, Nikita Chintam, Marco Amaya, Susanne E. Strand, Alero Mayuku-Dore, Indira Sakibova, Grace Maria Nicole Biso, Alejandro DeFilippis, Daniela Bravo, Nevzat Tarhan, Carsten Claussen, Alejandro Mercado, Serge Braun, Louis Yuge, Shigeo Okabe, Farhad Taghizadeh-Hesary, Konstantin Kotliar, Christina Sadowsky, P. Sarat Chandra, Manjari Tripathi, Vasileios Katsaros, Brian Mehling, Maryam Noroozian, Kazem Abbasioun, Abbas Amirjamshidi, Gholam-Ali Hossein-Zadeh, Faridedin Naraghi, Mojtaba Barzegar, Ali A. Asadi-Pooya, Sajad Sahab-Negah, Saeid Sadeghian, Margaret Fahnestock, Nesrin Dilbaz, Namath Hussain, Zoltan Mari, Robert W. Thatcher, Daniel Sipple, Kuldip Sidhu, Deepak Chopra, Francesco Costa, Giannantonio Spena, Ted Berger, Deborah Zelinsky, Christopher J. Wheeler, J. Wesson Ashford, Reinhard Schulte, M. A. Nezami, Harry Kloor, Aaron Filler, Dawn S. Eliashiv, Dipen Sinha, Antonio A.F. DeSalles, Venkatraman Sadanand, Sergey Suchkov, Ken Green, Barish Metin, Robert Hariri, Jason Cormier, Vicky Yamamoto & Babak Kateb. (2021) Neuroscience20 (BRAIN20, SPINE20, and MENTAL20) Health Initiative: A Global Consortium Addressing the Human and Economic Burden of Brain, Spine, and Mental Disorders Through Neurotech Innovations and Policies. Journal of Alzheimer's Disease 83:4, pages 1563-1601.
Crossref
Crossref
Seo Yeon Yoon, Han-Kyoul Kim, Mi Ji Kim, Jee Hyun Suh & Ja-Ho Leigh. (2021) Factors associated with assisted ventilation use in amyotrophic lateral sclerosis: a nationwide population-based study in Korea. Scientific Reports 11:1.
Crossref
Crossref
Gabriel Rodrigues Coutinho Pereira, Bárbara de Azevedo Abrahim Vieira & Joelma Freire De Mesquita. (2021) Comprehensive in silico analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis. PLOS ONE 16:2, pages e0247841.
Crossref
Crossref
Adrianna Gunton, Gregory Hansen & Kerri Lynn Schellenberg. (2021) Photovoice as a Participatory Research Tool in Amyotrophic Lateral Sclerosis. Journal of Neuromuscular Diseases 8:1, pages 91-99.
Crossref
Crossref
Wendy S. Johnston & Westerly Luth. 2021. Public Policy in ALS/MND Care. Public Policy in ALS/MND Care
77
96
.
Han SongJian-Chao Liu, Zi-Peng CaoWen-Jing LuoJing-Yuan Chen. (2020) Medical cost and healthcare utilization of amyotrophic lateral sclerosis in China. Medicine 99:47, pages e23258.
Crossref
Crossref
Jocelyn Zwicker, Danial Qureshi, Robert TalaricoPierre Bourque, Mary Scott, Nicolas Chin-Yee & Peter Tanuseputro. (2019) Dying of amyotrophic lateral sclerosis. Neurology 93:23.
Crossref
Crossref
Ileana Howard & Abigail Potts. (2019) Interprofessional Care for Neuromuscular Disease. Current Treatment Options in Neurology 21:8.
Crossref
Crossref
Gabriel Rodrigues Coutinho Pereira, Giovanni Henrique Almeida Silva Tellini & Joelma Freire De Mesquita. (2019) In silico analysis of PFN1 related to amyotrophic lateral sclerosis. PLOS ONE 14:6, pages e0215723.
Crossref
Crossref
Victoria L. Hodgkinson, Josh Lounsberry, Ario Mirian, Angela Genge, Timothy Benstead, Hannah Briemberg, Ian Grant, Walter Hader, Wendy S. Johnston, Sanjay Kalra, Gary Linassi, Rami Massie, Michel Melanson, Colleen O’Connell, Kerri Schellenberg, Christen Shoesmith, Sean Taylor, Scott Worley, Lorne Zinman & Lawrence Korngut. (2018) Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 45:6, pages 652-659.
Crossref
Crossref
Giancarlo Logroscino, Benoit Marin, Marco Piccininni, Simona Arcuti, Adriano Chiò, Orla Hardiman, James Rooney, Stefano Zoccolella, Philippe Couratier, Pierre-Marie Preux & Ettore Beghi. (2018) Referral bias in ALS epidemiological studies. PLOS ONE 13:4, pages e0195821.
Crossref
Crossref
A. Camacho, J. Esteban & C. Paradas. (2018) Report by the Spanish Foundation for the Brain on the social impact of amyotrophic lateral sclerosis and other neuromuscular disorders. Neurología (English Edition) 33:1, pages 35-46.
Crossref
Crossref
A. Camacho, J. Esteban & C. Paradas. (2018) Informe de la Fundación Del Cerebro sobre el impacto social de la esclerosis lateral amiotrófica y las enfermedades neuromusculares. Neurología 33:1, pages 35-46.
Crossref
Crossref
R. Spataro, P. Volanti, D. Lo Coco & V. La Bella. (2017) Marital status is a prognostic factor in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 136:6, pages 624-630.
Crossref
Crossref
Sabrina Paganoni, Katie Nicholson, Fawn Leigh, Kathryn Swoboda, David Chad, Kristin Drake, Kellen Haley, Merit Cudkowicz & James D. Berry. (2017) Developing multidisciplinary clinics for neuromuscular care and research. Muscle & Nerve 56:5, pages 848-858.
Crossref
Crossref
Alan Moore, Carolyn A. Young & Dyfrig A. Hughes. (2016) Economic Studies in Motor Neurone Disease: A Systematic Methodological Review. PharmacoEconomics 35:4, pages 397-413.
Crossref
Crossref
Christopher A. Shaw. 2017. Neural Dynamics of Neurological Disease. Neural Dynamics of Neurological Disease
301
354
.
Rachel McCormick & Katarzyna Goljanek-Whysall. 2017. MiRNAs in Aging and Cancer. MiRNAs in Aging and Cancer
265
308
.
Riley Golby, Brigitte Poirier, Marife Fabros, Jacquelyn J. Cragg, Masoud Yousefi & Neil Cashman. (2016) Five-Year Incidence of Amyotrophic Lateral Sclerosis in British Columbia (2010-2015). Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 43:6, pages 791-795.
Crossref
Crossref
Jaydeep M. Bhatt. (2016) The Epidemiology of Neuromuscular Diseases. Neurologic Clinics 34:4, pages 999-1021.
Crossref
Crossref
Estefanía de Munck, Valle Palomo, Emma Muñoz-Sáez, Daniel I. Perez, Begoña Gómez-Miguel, M. Teresa Solas, Carmen Gil, Ana Martínez & Rosa M. Arahuetes. (2016) Small GSK-3 Inhibitor Shows Efficacy in a Motor Neuron Disease Murine Model Modulating Autophagy. PLOS ONE 11:9, pages e0162723.
Crossref
Crossref
Sabrina Paganoni, Chafic Karam, Nanette Joyce, Richard Bedlack & Gregory T. Carter. (2015) Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation 37:1, pages 53-68.
Crossref
Crossref